Central monoamines and antinociceptive drug action.
D000632:Aminopyrine / Q000037:antagonists & inhibitors*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D001933:Brain Stem / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D002713:Chlorine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors*; D004221:Disulfiram / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009020:Morphine / Q000037:antagonists & inhibitors*; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology*; D013997:Time Factors
D002395:Catecholamines; D008781:Methyltyrosines; D000632:Aminopyrine; D003533:Cyproheptadine; D012701:Serotonin; D002713:Chlorine; D009020:Morphine; D006220:Haloperidol; D010134:Fenclonine; D004221:Disulfiram; D003913:Dextroamphetamine; D002746:Chlorpromazine; D010646:Phentolamine